These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34575784)

  • 21. Quality control of fifteen probiotic products containing Saccharomyces boulardii.
    Vanhee LM; Goemé F; Nelis HJ; Coenye T
    J Appl Microbiol; 2010 Nov; 109(5):1745-52. PubMed ID: 20636342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Yeast modulation of human dendritic cell cytokine secretion: an in vitro study.
    Smith IM; Christensen JE; Arneborg N; Jespersen L
    PLoS One; 2014; 9(5):e96595. PubMed ID: 24816850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Saccharomyces boulardii CNCM I-745: A Non-bacterial Microorganism Used as Probiotic Agent in Supporting Treatment of Selected Diseases.
    Kaźmierczak-Siedlecka K; Ruszkowski J; Fic M; Folwarski M; Makarewicz W
    Curr Microbiol; 2020 Sep; 77(9):1987-1996. PubMed ID: 32472262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and Growth Characterization of a Novel Strain of
    Hossain MN; Afrin S; Humayun S; Ahmed MM; Saha BK
    Front Nutr; 2020; 7():27. PubMed ID: 32309286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating the probiotic and therapeutic potentials of Saccharomyces cerevisiae strain (OBS2) isolated from fermented nectar of toddy palm.
    Srinivas B; Rani GS; Kumar BK; Chandrasekhar B; Krishna KV; Devi TA; Bhima B
    AMB Express; 2017 Dec; 7(1):2. PubMed ID: 28050843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selection on plastic adherence leads to hyper-multicellular strains and incidental virulence in the budding yeast.
    Ekdahl LI; Salcedo JA; Dungan MM; Mason DV; Myagmarsuren D; Murphy HA
    Elife; 2023 Nov; 12():. PubMed ID: 37916911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diversity of
    Czerucka D; Rampal P
    World J Gastroenterol; 2019 May; 25(18):2188-2203. PubMed ID: 31143070
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Diguță CF; Mihai C; Toma RC; Cîmpeanu C; Matei F
    Foods; 2022 Dec; 12(1):. PubMed ID: 36613340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antagonistic effect of Saccharomyces cerevisiae KTP and Issatchenkia occidentalis ApC on hyphal development and adhesion of Candida albicans.
    Lohith K; Anu-Appaiah KA
    Med Mycol; 2018 Nov; 56(8):1023-1032. PubMed ID: 29340656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro screening of probiotic properties of Saccharomyces cerevisiae var. boulardii and food-borne Saccharomyces cerevisiae strains.
    van der Aa Kühle A; Skovgaard K; Jespersen L
    Int J Food Microbiol; 2005 May; 101(1):29-39. PubMed ID: 15878404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modeling the Ethanol Tolerance of the Probiotic Yeast Saccharomyces cerevisiae var. boulardii CNCM I-745 for its Possible Use in a Functional Beer.
    Ramírez-Cota GY; López-Villegas EO; Jiménez-Aparicio AR; Hernández-Sánchez H
    Probiotics Antimicrob Proteins; 2021 Feb; 13(1):187-194. PubMed ID: 32613533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Saccharomyces boulardii and Candida albicans experimental colonization of the murine gut.
    Samonis G; Falagas ME; Lionakis S; Ntaoukakis M; Kofteridis DP; Ntalas I; Maraki S
    Med Mycol; 2011 May; 49(4):395-9. PubMed ID: 21077734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fungemia following Saccharomyces cerevisiae var. boulardii probiotic treatment in an elderly patient.
    Landaburu MF; López Daneri GA; Relloso S; Zarlenga LJ; Vinante MA; Mujica MT
    Rev Argent Microbiol; 2020; 52(1):27-30. PubMed ID: 31262611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probiotic potential of Saccharomyces strains isolated from Litchi chinensis (Lychee fruit).
    Khan M; Ahmed I; Farooq S; Khan S; Amin R; Ali S
    Pak J Pharm Sci; 2020 Jul; 33(4(Supplementary)):1855-1861. PubMed ID: 33612470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genotypic and physiological characterization of Saccharomyces boulardii, the probiotic strain of Saccharomyces cerevisiae.
    Edwards-Ingram L; Gitsham P; Burton N; Warhurst G; Clarke I; Hoyle D; Oliver SG; Stateva L
    Appl Environ Microbiol; 2007 Apr; 73(8):2458-67. PubMed ID: 17293506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of Saccharomyces boulardii on Candida albicans-infected human intestinal cell lines Caco-2 and Intestin 407.
    Murzyn A; Krasowska A; Augustyniak D; Majkowska-Skrobek G; Łukaszewicz M; Dziadkowiec D
    FEMS Microbiol Lett; 2010 Sep; 310(1):17-23. PubMed ID: 20629753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Saccharomyces boulardii CNCM I-745 - the medicinal yeast improves intestinal enzyme function].
    Moré MI
    MMW Fortschr Med; 2019 Mar; 161(Suppl 4):20-24. PubMed ID: 30895510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biodiversity and probiotic potential of yeasts isolated from Fura, a West African spontaneously fermented cereal.
    Pedersen LL; Owusu-Kwarteng J; Thorsen L; Jespersen L
    Int J Food Microbiol; 2012 Oct; 159(2):144-51. PubMed ID: 23072700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the time course of the effects of the probiotic yeast Saccharomyces boulardii on electrolyte transport in pig jejunum.
    Schroeder B; Winckler C; Failing K; Breves G
    Dig Dis Sci; 2004 Aug; 49(7-8):1311-7. PubMed ID: 15387362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of Saccharomyces cerevisiae var. boulardii in co-fermentations with S. cerevisiae for the production of craft beers with potential healthy value-added.
    Capece A; Romaniello R; Pietrafesa A; Siesto G; Pietrafesa R; Zambuto M; Romano P
    Int J Food Microbiol; 2018 Nov; 284():22-30. PubMed ID: 29990636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.